Bovine Tuberculosis Diagnosis Market Size, Share, Growth, and Industry Analysis, By Type (Personal,Commercial), By Application (Serological Tests,Molecular Diagnostic Tests,Traditional Tests), Regional Insights and Forecast to 2035

Bovine Tuberculosis Diagnosis Market Overview

The global Bovine Tuberculosis Diagnosis Market is forecast to expand from USD 1057.11 million in 2026 to USD 1109.65 million in 2027, and is expected to reach USD 1635.71 million by 2035, growing at a CAGR of 4.97% over the forecast period.

The Bovine Tuberculosis Diagnosis Market is witnessing strong global adoption due to the rising need for efficient disease detection in cattle populations exceeding 1.5 billion worldwide. With approximately 59.4% of total tests conducted using traditional methods and about 40% involving molecular techniques, diagnostic efficiency has increased significantly.

The United States holds one of the largest market shares in the global Bovine Tuberculosis Diagnosis Market, driven by a national cattle inventory exceeding 94 million head in 2023. Approximately 80% of U.S. dairy herds undergo regular screening using tuberculin skin tests and gamma interferon assays.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Around 65% of global testing demand is driven by government-mandated herd surveillance programs and trade compliance requirements.
• Major Market Restraint: Nearly 30% of potential diagnostic adoption is hindered by infrastructure and cost limitations in low-resource regions.
• Emerging Trends: Roughly 45% of new diagnostic systems introduced in 2023 were molecular-based solutions targeting enhanced sensitivity.
• Regional Leadership: North America leads with approximately 37.6% global market share, followed by Europe with around 35%.
• Competitive Landscape: The top two market players collectively control about 36% of total global market share.
• Market Segmentation: Traditional testing methods hold nearly 59% of all diagnostic applications globally.
• Recent Development: About 40% of recent diagnostic innovations between 2023–2024 focused on rapid PCR and phage-based testing solutions.

Bovine Tuberculosis Diagnosis Market Latest Trends

The Bovine Tuberculosis Diagnosis Market is characterized by rapid technological transformation and increasing global surveillance programs. Molecular testing systems now represent approximately 42% of total diagnostic installations worldwide, a significant increase from previous years. Traditional tuberculin and gamma interferon assays still dominate, maintaining a 59.4% market share due to their affordability and regulatory acceptance.

Bovine Tuberculosis Diagnosis Market Dynamics

The Bovine Tuberculosis Diagnosis Market Dynamics reflect the interaction of regulatory mandates, disease surveillance needs, and technological innovation. Rising herd populations exceeding 1.5 billion globally, combined with mandatory screening across more than 60 countries, are driving demand for faster and more accurate diagnostic solutions.

DRIVER

"Rising demand for advanced diagnostic tools"

The primary driver influencing the Bovine Tuberculosis Diagnosis Market is the growing global requirement for reliable diagnostic solutions in large-scale cattle herds. With over 1.5 billion cattle worldwide, governments are intensifying surveillance initiatives—accounting for nearly 65% of total diagnostic demand. Molecular diagnostic systems have improved disease detection accuracy by 35%, reducing the risk of false negatives and enhancing early-stage detection. The widespread implementation of tuberculin testing, along with the adoption of gamma interferon assays, enables accurate herd-level screening in over 75% of regulated markets.

RESTRAINT

"Limited infrastructure and diagnostic accessibility"

A major restraint within the Bovine Tuberculosis Diagnosis Market arises from limited veterinary infrastructure, particularly in low-income regions. In sub-Saharan Africa and parts of South Asia, less than 25% of target herds undergo annual testing due to cost constraints and inadequate laboratory capacity. Molecular diagnostic kits can exceed several thousand dollars in setup and operation, restricting adoption to larger commercial farms. Consequently, traditional tuberculin skin tests—representing 58% of global usage—remain the preferred method in rural environments despite sensitivity limitations of approximately 70–80%.

OPPORTUNITY

"Expansion into emerging livestock markets"

Emerging economies present substantial opportunities for the Bovine Tuberculosis Diagnosis Market. Asia-Pacific and Africa together account for nearly 60% of global cattle populations, yet diagnostic coverage remains below 45%. Increasing investments in veterinary health infrastructure and herd certification programs are expected to boost testing adoption by 30–35% within the next few years. The introduction of affordable portable diagnostic kits—representing 10% of new systems introduced in 2023—offers significant potential for decentralized, field-level testing. 

CHALLENGE

"High false-negative rates and cross-species infection"

One of the core challenges in the Bovine Tuberculosis Diagnosis Market is achieving consistent test accuracy across diverse herd conditions. Traditional tuberculin skin tests can exhibit false-negative rates as high as 25–30%, depending on environmental factors and animal immune responses. Molecular assays, though more reliable, require controlled sample collection and technical expertise that limit their field usability in remote areas. Wildlife reservoirs such as deer and badgers contribute to approximately 15% of new bovine tuberculosis cases, complicating containment efforts.

Bovine Tuberculosis Diagnosis Market Segmentation

The Bovine Tuberculosis Diagnosis Market Segmentation is structured by type and application, addressing both commercial and on-farm diagnostic needs. By type, commercial laboratories represent about 90% of total testing, while personal diagnostic kits account for the remaining 10%, primarily in small-scale farms. By application, traditional tuberculin tests dominate with a 59% share, followed by molecular diagnostics at 42% and serological assays near 30%, reflecting overlapping usage for confirmation and screening.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Personal: The personal testing segment in the Bovine Tuberculosis Diagnosis Market caters to small and medium-sized farms conducting on-site diagnostics without laboratory infrastructure. Approximately 10% of all diagnostic devices are designed for on-farm use, focusing on affordability and simplicity. These portable kits enable early disease detection and reduce spread within localized herds of fewer than 500 cattle.

The Personal Type segment of the Bovine Tuberculosis Diagnosis Market is estimated to hold a valuation of USD 135.6 million in 2025, capturing approximately 13.46% of the total market share and expected to grow at a CAGR of 5.1% until 2034, supported by increased adoption of portable on-farm diagnostic kits and expanding herd monitoring requirements in small and medium-sized livestock farms.

Top 5 Major Dominant Countries in the Personal Type Segment

• United States: The United States is projected to register a market size of USD 34.5 million in 2025, capturing 25.4% of the segment share, expanding at a CAGR of 5.2%, driven by digital herd monitoring adoption.
• China: China’s personal testing market is expected to reach USD 28.8 million in 2025, holding a 21.2% share and projected to grow at a CAGR of 5.5%, supported by rising dairy herd expansion and rural testing initiatives.
• India: India will record a market size of USD 19.2 million in 2025, representing 14.1% of the global segment, growing at a CAGR of 5.7%, attributed to government disease control programs in rural cattle communities.
• Brazil: Brazil’s personal testing segment will attain USD 16.4 million in 2025, contributing 12.1% share and expanding at CAGR of 5.3%, driven by dairy herd modernization and regional veterinary investments.
• Germany: Germany is forecasted to reach USD 13.5 million in 2025, occupying 9.9% share with a CAGR of 5.0%, propelled by precision diagnostic adoption in small-scale dairy operations and herd health certification programs.

Commercial: The commercial segment dominates the Bovine Tuberculosis Diagnosis Market, accounting for nearly 90% of total testing volume globally. Large-scale testing programs conducted by veterinary laboratories and government agencies process hundreds of thousands of samples annually. The segment includes centralized diagnostic services using gamma interferon assays, ELISA tests, and PCR-based methods that achieve up to 95% detection accuracy.

The Commercial Type segment is expected to dominate the Bovine Tuberculosis Diagnosis Market with an estimated market size of USD 871.46 million in 2025, accounting for approximately 86.54% of total market share and forecasted to grow at a CAGR of 4.9% through 2034, driven by expansion of centralized laboratory diagnostics and mandatory national bovine tuberculosis screening initiatives.

Top 5 Major Dominant Countries in the Commercial Type Segment

• United States: The U.S. commercial testing market will achieve USD 215.8 million in 2025, representing 24.7% of the global share and expanding at CAGR of 4.8%, led by regulatory herd surveillance and diagnostic automation.
• United Kingdom: The UK will reach USD 132.6 million in 2025, accounting for 15.2% share, growing at a CAGR of 5.0%, driven by extensive government-funded eradication programs and annual herd testing protocols.
• Germany: Germany’s commercial segment is expected to total USD 112.4 million in 2025, equating to 12.9% of market share and increasing at a CAGR of 4.9%, supported by continuous technology upgrades in veterinary laboratories.
• China: China’s commercial diagnostics are projected at USD 96.2 million in 2025, contributing 11% share and expanding at a CAGR of 5.1%, driven by livestock modernization and public health investments.
• France: France is estimated to hold USD 78.6 million in 2025, equal to 9% share and anticipated to grow at CAGR of 4.8%, influenced by regional veterinary testing mandates and dairy export certification needs.

BY APPLICATION

Serological Tests: Serological assays represent approximately 30% of total applications within the Bovine Tuberculosis Diagnosis Market. ELISA-based antibody detection techniques are widely used for herd-level screening and epidemiological studies. Their affordability and rapid turnaround make them suitable for large-scale implementation, particularly in developing nations.

The Serological Tests segment of the Bovine Tuberculosis Diagnosis Market is expected to hold a valuation of USD 271.9 million in 2025, accounting for 27% of the total share, and is forecasted to grow at a CAGR of 5.2% through 2034.

Top 5 Major Dominant Countries in the Serological Tests Application

• United States: The U.S. market for serological tests is valued at USD 69.5 million in 2025, securing 25.5% share with a CAGR of 5.3%, driven by ELISA-based surveillance across federal livestock programs.
• Germany: Germany’s serological testing market will reach USD 45.2 million in 2025, comprising 16.6% share, expanding at CAGR of 5.1%, supported by continuous herd-level antibody monitoring initiatives.
• China: China will record USD 39.8 million in 2025, holding 14.6% market share and growing at a CAGR of 5.5%, propelled by dairy sector testing investments and national animal health campaigns.
• Brazil: Brazil’s serological diagnostics segment will total USD 33.4 million in 2025, equal to 12.3% share, with CAGR of 5.2%, backed by government-backed cattle disease screening programs.
• United Kingdom: The UK is projected to register USD 27.6 million in 2025, securing 10.1% share, with a CAGR of 4.9%, driven by national tuberculosis reduction strategies and certified disease-free herd protocols.

Molecular Diagnostic Tests: Molecular diagnostics currently account for around 42% of new test installations in the Bovine Tuberculosis Diagnosis Market. These include PCR, real-time PCR, and next-generation sequencing methods with sensitivity exceeding 95%. Molecular tests enable early-stage detection within 24 hours, providing a substantial improvement over traditional testing timelines.

The Molecular Diagnostic Tests segment is projected to achieve a market valuation of USD 422.9 million in 2025, representing 41.9% of the total share, expanding at a CAGR of 5.4% owing to increased accuracy and faster detection turnaround.

Top 5 Major Dominant Countries in the Molecular Diagnostic Tests Application

• United States: The U.S. molecular testing market will reach USD 115.7 million in 2025, representing 27.3% share and expanding at CAGR of 5.4%, driven by laboratory digitization and early detection policies.
• China: China’s molecular diagnostics will total USD 86.1 million in 2025, accounting for 20.3% share and projected to expand at CAGR of 5.6%, backed by genomic technology advancements and herd modernization.
• Germany: Germany will register USD 63.4 million in 2025, equal to 15% market share and growing at a CAGR of 5.1%, supported by laboratory automation in commercial testing facilities.
• India: India’s molecular diagnostics market will reach USD 47.9 million in 2025, comprising 11.3% share and increasing at CAGR of 5.5%, boosted by rapid adoption of PCR-based veterinary assays.
• France: France’s molecular diagnostic testing value is USD 36.2 million in 2025, securing 8.5% share, expanding at CAGR of 5.0%, primarily due to export certification and advanced animal health compliance initiatives.

Traditional Tests: Traditional diagnostics, including the tuberculin skin test and gamma interferon assay, retain about 59% market share in the Bovine Tuberculosis Diagnosis Market. These tests remain widely accepted by global regulatory bodies for official herd certification. Traditional tests are performed on millions of cattle annually across North America and Europe, with average accuracy rates between 80–85%.

The Traditional Tests segment continues to dominate the Bovine Tuberculosis Diagnosis Market with a market size of USD 312.2 million in 2025, representing 31% of the global share and growing at a CAGR of 4.5% through 2034.

Top 5 Major Dominant Countries in the Traditional Tests Application

• United States: The U.S. traditional testing market is projected at USD 79.4 million in 2025, representing 25.4% share, increasing at CAGR of 4.6%, supported by continued use of tuberculin skin tests in federal programs.
• United Kingdom: The UK will record USD 61.8 million in 2025, equating to 19.8% share and expanding at CAGR of 4.8%, driven by national mandatory herd-testing operations.
• France: France will reach USD 49.5 million in 2025, representing 15.9% of total share and increasing at CAGR of 4.7%, due to long-standing disease control legislation.
• Germany: Germany’s traditional test market stands at USD 46.1 million in 2025, securing 14.8% share and advancing at CAGR of 4.5%, led by standardized tuberculin testing frameworks.
• China: China’s traditional diagnostics value is USD 37.2 million in 2025, covering 11.9% share and growing at CAGR of 4.9%, driven by rural cattle surveillance and veterinary awareness programs.

Regional Outlook for the Bovine Tuberculosis Diagnosis Market

Regionally, the Bovine Tuberculosis Diagnosis Market demonstrates varied performance due to differences in regulatory enforcement, livestock population density, and technological adoption. North America leads with approximately 37.6% market share, followed by Europe at 35%, Asia-Pacific around 20%, and the Middle East & Africa at roughly 7%. Herd surveillance coverage exceeds 80% in developed regions but remains under 45% in emerging markets.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America remains the leading region in the Bovine Tuberculosis Diagnosis Market, accounting for nearly 37.6% of global share. The United States, with approximately 94 million cattle, operates one of the world’s most comprehensive tuberculosis eradication programs. Over 500,000 tests are conducted annually under federal and state supervision, maintaining national prevalence rates below 0.05%.

The North America Bovine Tuberculosis Diagnosis Market: is projected to achieve a valuation of USD 389.6 million by 2025, accounting for approximately 38.7% of the total global market share, and is anticipated to expand steadily at a CAGR of 4.8% through 2034, primarily driven by extensive implementation of disease surveillance programs, rapid technological integration in molecular diagnostics, and robust government-backed bovine tuberculosis eradication initiatives across the United States, Canada, and Mexico.

North America – Major Dominant Countries

• United States: The United States dominates the North American Bovine Tuberculosis Diagnosis Market, registering a market size of USD 296.4 million in 2025, representing nearly 76% of the regional market share, and is expected to record a CAGR of 4.9% through 2034, supported by one of the world’s most comprehensive veterinary diagnostic infrastructures, large-scale herd surveillance programs, and advanced molecular testing adoption across over 90 million cattle nationwide.
• Canada: Canada is projected to reach a market valuation of USD 54.8 million in 2025, contributing approximately 14.1% to the regional share, with steady expansion at a CAGR of 4.7%, primarily fueled by the country’s national livestock monitoring system, well-established veterinary diagnostic laboratories, and government-funded programs promoting herd testing and certification for tuberculosis-free status within the dairy and beef sectors.
• Mexico: In Mexico, the Bovine Tuberculosis Diagnosis Market is anticipated to achieve a market value of USD 26.5 million in 2025, equivalent to 6.8% of the total regional market, advancing at a CAGR of 4.6%, largely driven by growing investments in livestock disease prevention infrastructure, expansion of national beef export programs requiring tuberculosis testing certification, and the steady modernization of veterinary diagnostic services across public and private sectors.
• Cuba: Cuba is estimated to secure a market size of USD 7.8 million in 2025, capturing nearly 2% of the regional market share, and is forecasted to grow at a CAGR of 4.5% through 2034, attributed to ongoing government-led cattle vaccination initiatives, improved veterinary training, and national campaigns emphasizing tuberculosis detection and eradication across small and medium-sized dairy farms to strengthen herd health management.
• Costa Rica: Costa Rica is projected to register a market valuation of USD 4.1 million in 2025, representing 1.1% of the North American market share, and expected to grow at a CAGR of 4.4% during the forecast period, driven by expanding dairy sector investments, improved veterinary testing capabilities, and the country’s increasing focus on achieving disease-free certification to enhance regional milk and beef export competitiveness.

EUROPE

Europe holds around 35% of the global Bovine Tuberculosis Diagnosis Market share, supported by extensive veterinary infrastructure and robust disease control regulations. The European cattle population surpasses 60 million, with regular testing enforced by national agencies. Countries such as the United Kingdom, Germany, and France conduct combined annual testing volumes exceeding 1 million cattle per year.

The Europe Bovine Tuberculosis Diagnosis Market: is projected to attain a valuation of USD 352.1 million in 2025, representing approximately 34.9% of the global market share, and is expected to expand at a CAGR of 5.0% through 2034.

Europe – Major Dominant Countries

• United Kingdom: The United Kingdom is projected to achieve a market size of USD 98.4 million in 2025, capturing approximately 27.9% of the regional share, and is anticipated to grow at a CAGR of 5.1% through 2034, driven by government-enforced herd testing mandates, advanced molecular diagnostic applications, and strong veterinary compliance measures focused on reducing bovine tuberculosis prevalence across dairy and beef herds.
• Germany: Germany is expected to register a market valuation of USD 82.6 million in 2025, accounting for 23.4% of Europe’s market share, and expanding at a CAGR of 4.9%, supported by the country’s highly developed diagnostic infrastructure, integration of PCR-based technologies, and nationwide implementation of animal health certification programs ensuring disease-free herd status in both dairy and meat sectors.
• France: France is forecasted to record a market size of USD 67.2 million in 2025, representing 19% of the regional market, and will grow at a CAGR of 4.8%, primarily driven by stringent EU-aligned veterinary legislation, continuous disease surveillance investments, and a well-established network of public and private diagnostic laboratories supporting nationwide bovine health initiatives.
• Italy: Italy is projected to reach a market valuation of USD 54.8 million in 2025, securing 15.5% of the Europe market share, and advancing at a CAGR of 5.0%, supported by increasing testing adoption across dairy-intensive regions, technological modernization in herd management systems, and government-funded tuberculosis eradication schemes aligned with European health standards.
• Spain: Spain is expected to achieve a market size of USD 49.1 million in 2025, representing 13.9% of the regional market, and is anticipated to grow at a CAGR of 5.2%, driven by progressive veterinary reforms, enhanced livestock traceability infrastructure, and active regional participation in cross-border disease monitoring and tuberculosis control initiatives across southern Europe.

ASIA-PACIFIC

The Asia-Pacific region represents the fastest-developing segment of the Bovine Tuberculosis Diagnosis Market, with cattle populations exceeding 650 million head. China and India together account for more than 50% of the region’s market share, driven by expanding dairy and beef production industries. Diagnostic adoption has grown by over 30% in the last three years, supported by national veterinary reforms and public health initiatives.

The Asia Bovine Tuberculosis Diagnosis Market: is projected to attain a total valuation of USD 196.4 million in 2025, accounting for approximately 19.5% of global market share, and is expected to expand at a CAGR of 5.3% through 2034.

Asia – Major Dominant Countries

• China: China is expected to achieve a market size of USD 78.5 million in 2025, capturing approximately 40% of the regional market share, and is forecasted to expand at a CAGR of 5.5% through 2034, driven by large-scale livestock surveillance programs, dairy sector modernization, and technological investments in molecular and serological diagnostics improving national disease detection efficiency.
• India: India is projected to record a market valuation of USD 51.7 million in 2025, accounting for 26.3% of Asia’s market, and is anticipated to grow at a CAGR of 5.4%, supported by government-led veterinary awareness campaigns, expansion of dairy cooperatives, and the deployment of cost-effective testing systems designed to reach rural cattle populations.
• Japan: Japan is estimated to reach a market size of USD 28.3 million in 2025, representing 14.4% of the regional share, and will expand at a CAGR of 5.0%, primarily driven by advanced PCR-based diagnostic adoption, stringent animal health regulations, and strong national emphasis on disease-free livestock certification.
• Australia: Australia is forecasted to record a market valuation of USD 23.7 million in 2025, contributing 12.1% to the regional share, and growing at a CAGR of 5.1%, supported by the implementation of comprehensive biosecurity measures, digital herd management systems, and proactive tuberculosis monitoring initiatives across dairy and beef farms.
• South Korea: South Korea is projected to register a market size of USD 14.2 million in 2025, representing 7.2% of the regional share, and expanding at a CAGR of 5.2%, driven by strong government investments in animal disease surveillance programs, growing utilization of molecular diagnostics, and the expansion of domestic veterinary service networks.

MIDDLE EAST & AFRICA

The Bovine Tuberculosis Diagnosis Market in the Middle East & Africa remains at an early stage but shows strong growth potential. Current diagnostic coverage across African cattle herds, estimated at over 300 million head, is below 25%, indicating significant untapped demand. Several national livestock programs have increased testing volumes by 15–20% between 2023 and 2025, emphasizing zoonotic disease control.

The Middle East & Africa Bovine Tuberculosis Diagnosis Market: is expected to reach a combined valuation of USD 68.9 million in 2025, representing approximately 6.8% of the global market share, and is projected to grow at a CAGR of 4.6% through 2034.

Middle East & Africa – Major Dominant Countries

• Saudi Arabia: Saudi Arabia is expected to reach a market size of USD 17.4 million in 2025, accounting for 25.2% of the regional market share, and growing at a CAGR of 4.7%, driven by expanding government livestock health programs, establishment of centralized testing laboratories, and regulatory mandates for herd-level disease monitoring in dairy farms.
• South Africa: South Africa is forecasted to record a market valuation of USD 14.9 million in 2025, representing 21.6% of regional share, and expanding at a CAGR of 4.6%, supported by strengthened veterinary infrastructure, national dairy herd surveillance programs, and partnerships promoting bovine disease testing across public and private veterinary institutions.
• United Arab Emirates: The United Arab Emirates is anticipated to achieve a market value of USD 12.3 million in 2025, accounting for 17.9% of the regional share, and growing at a CAGR of 4.8%, primarily driven by rising livestock trade, the expansion of veterinary diagnostic laboratories, and investments in portable molecular testing devices.
• Egypt: Egypt is expected to register a market valuation of USD 11.8 million in 2025, representing 17.1% of the total regional market, and growing at a CAGR of 4.5%, supported by modernization of veterinary laboratories, disease surveillance funding, and increased adoption of cost-effective diagnostic technologies in both rural and industrial livestock operations.
• Nigeria: Nigeria is projected to achieve a market size of USD 9.4 million in 2025, contributing approximately 13.6% to the regional market share, and expanding at a CAGR of 4.4%, driven by government veterinary capacity-building programs, expansion of rural disease testing centers, and ongoing initiatives to improve livestock productivity and biosecurity.

List of Top Bovine Tuberculosis Diagnosis Companies

• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific Inc.
• Bionote
• IDEXX Laboratories, Inc.
• Enfer Group
• AsureQuality Australia Pty Ltd.
• IDvet
• Zoetis
• PBD Biotech Ltd.

IDEXX Laboratories, Inc.: Holds approximately 24% of the global Bovine Tuberculosis Diagnosis Market share and is the leading provider of advanced veterinary diagnostics worldwide.

PBD Biotech Ltd.: Accounts for nearly 12% of total global market share, recognized for developing rapid molecular tuberculosis diagnostic systems with improved sensitivity and turnaround times.

Investment Analysis and Opportunities

Investments within the Bovine Tuberculosis Diagnosis Market are primarily directed toward advanced molecular diagnostic development, laboratory automation, and herd-health data integration. Between 2023 and 2025, diagnostic technology investments rose by nearly 25%, driven by demand for faster, more accurate detection methods.

New Product Development

Innovation in the Bovine Tuberculosis Diagnosis Market is rapidly advancing, with molecular, serological, and phage-based diagnostics dominating new product pipelines. In 2023, approximately 45% of product introductions were molecular assays capable of delivering results within 4 hours.

Five Recent Developments

• A phage-based diagnostic assay introduced in early 2023 reduced testing time to under 4 hours, achieving 95% sensitivity in pilot studies.
• In 2023, over 600,000 bovine tuberculosis tests were administered across European farms under government surveillance programs.
• Portable diagnostic kits introduced in 2024 accounted for 10% of new global testing equipment, improving rural accessibility.
• A major partnership launched in 2024 between diagnostic manufacturers and Middle Eastern agencies increased regional testing by 20%.
• In 2025, a multiplex diagnostic platform detecting up to 5 bovine diseases concurrently achieved 8% of new equipment installations globally.

Report Coverage of Bovine Tuberculosis Diagnosis Market

The Bovine Tuberculosis Diagnosis Market Report provides an in-depth evaluation of global market dynamics, segmentation, technological trends, and competitive analysis across regions. It covers test types such as traditional assays, molecular diagnostics, and serological tests, along with type-based segmentation into personal and commercial diagnostics.

Bovine Tuberculosis Diagnosis Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 1057.11 Million in 2026
Market Size Value By	USD 1635.71 Million by 2035
Growth Rate	CAGR of 4.97% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Personal Commercial By Application : Serological Tests Molecular Diagnostic Tests Traditional Tests
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample